Porcine vagina ex vivo as a model for studying permeability and pathogenesis in mucosa.
about
A review of the human vs. porcine female genital tract and associated immune system in the perspective of using minipigs as a model of human genital Chlamydia infectionQuantitative analysis of microbicide concentrations in fluids, gels and tissues using confocal Raman spectroscopyCytolysins augment superantigen penetration of stratified mucosaProinflammatory exoprotein characterization of toxic shock syndrome Staphylococcus aureus.Commensal bacteria modulate innate immune responses of vaginal epithelial cell multilayer culturesEpithelial proinflammatory response and curcumin-mediated protection from staphylococcal toxic shock syndrome toxin-1Staphylococcal and streptococcal superantigen exotoxinsDevelopment of an in vitro alternative assay method for vaginal irritation.Vaginal microbicide gel for delivery of IQP-0528, a pyrimidinedione analog with a dual mechanism of action against HIV-1.Comparative biophysical properties of tenofovir-loaded, thiolated and nonthiolated chitosan nanoparticles intended for HIV preventionThe vaginal microbiome is stable in prepubertal and sexually mature Ellegaard Göttingen Minipigs throughout an estrous cycleLactobacillus crispatus inhibits growth of Gardnerella vaginalis and Neisseria gonorrhoeae on a porcine vaginal mucosa model.Engineering tenofovir loaded chitosan nanoparticles to maximize microbicide mucoadhesion.Local Epidermal Growth Factor Receptor Signaling Mediates the Systemic Pathogenic Effects of Staphylococcus aureus Toxic Shock SyndromeGenital tract lesions in sexually mature Göttingen minipigs during the initial stages of experimental vaginal infection with Chlamydia trachomatis serovar D.Alpha-toxin promotes Staphylococcus aureus mucosal biofilm formation.A mucosal model to study microbial biofilm development and anti-biofilm therapeutics.Novel toxic shock syndrome toxin-1 amino acids required for biological activity.Pharmaceutical development of microbicide drug products.A novel vaginal microbicide containing the rationally designed anti-HIV compound HI-443 (N'-[2-(2-thiophene)ethyl]-N'-[2-(5-bromopyridyl)] thiourea]).Optimizing efficacy of mucosal vaccines.Novel Spray Dried Glycerol 2-Phosphate Cross-Linked Chitosan Microparticulate Vaginal Delivery System-Development, Characterization and Cytotoxicity Studies.Development and characterization of a three-dimensional organotypic human vaginal epithelial cell model.Ex vivo effect of gold nanoparticles on porcine synovial membrane.Label-free analysis of tenofovir delivery to vaginal tissue using co-registered confocal Raman spectroscopy and optical coherence tomography.Multifunctional Tannic Acid/Silver Nanoparticle-Based Mucoadhesive Hydrogel for Improved Local Treatment of HSV Infection: In Vitro and In Vivo Studies.Drug-free chitosan coated poly(isobutylcyanoacrylate) nanoparticles are active against trichomonas vaginalis and non-toxic towards pig vaginal mucosa.Onset of puberty and normal histological appearances of the reproductive organs in peripubertal female Göttingen minipigs.Use of an Ex Vivo Porcine Mucosal Model to Study Superantigen Penetration.Full depth measurement of tenofovir transport in rectal mucosa using confocal Raman spectroscopy and optical coherence tomography.
P2860
Q26786555-1F3166C4-DBE9-42ED-B523-2403F405500FQ28538105-04151782-99ED-4228-9D87-4D2A39162988Q33585467-5057A1A8-67EF-4EB0-BA88-04735C627C8AQ33958583-0F30FA9D-6C7E-4683-BA8B-3D62824BCB1CQ34193360-31E75BF9-AF99-4E80-A1A2-BCEB2A5A5A0AQ34202778-95279100-1502-4DC1-97DB-DC8E71BE3747Q34355243-B9DF5364-70CA-46E6-A18C-DC4F90FB68C2Q34414296-BAC3BE05-1FE1-48C1-B81E-0B15D044479CQ34737582-9B11102D-0BBB-497C-96B7-14EE47977CAFQ34784522-1527DD10-CA4B-4014-9A5C-62C5F6C83E06Q35824726-DE750D45-9741-40CA-8D83-56D431F7A9FBQ35865121-73146981-D310-4304-8952-D63D79C84BA5Q36032477-2BBB0089-875D-4611-AD82-5E06BC94F3C1Q36077299-B61F955B-DC06-488D-B88E-465AA0E390A4Q36129347-95C66894-C118-447C-9E36-623330B03AC0Q36158880-A02BEC61-38B7-4E06-B506-F7BC7FECB19EQ36604834-4E3C98AC-7D55-4F92-AAD4-23B1366706DBQ37104985-F827911B-B7C3-4A66-A66A-D9C1DE0C8732Q37657468-4B90AB60-CFD5-4A15-A2A7-71F780F24019Q37980177-A5C10561-7370-496F-B5C1-CCC580D84DF0Q38059754-0A2735A2-9705-4748-B26C-C531E3EE1D94Q39334418-2B5A2BE0-F836-412C-BA80-4546D1ED66A2Q39763796-1B0267E4-0F0C-47CC-8914-EB69E98A957CQ41847614-784DF799-8520-470F-8AD9-667CB346D2A1Q42367545-B65CBFDC-B443-468F-8E0C-C1B5DEEFFE08Q47547867-B991AEE8-AB94-42E2-A6DC-752FAF53D750Q51042386-34CBA41B-6504-4930-BA81-A8ECA0574543Q51245437-5A9A6DD8-F4CA-4454-A35C-6543FB0E555EQ53241560-9996E0E3-AE76-47DB-A42E-84690C93B9F1Q53450140-82156441-006F-4A34-809C-C391F036B84F
P2860
Porcine vagina ex vivo as a model for studying permeability and pathogenesis in mucosa.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Porcine vagina ex vivo as a model for studying permeability and pathogenesis in mucosa.
@en
type
label
Porcine vagina ex vivo as a model for studying permeability and pathogenesis in mucosa.
@en
prefLabel
Porcine vagina ex vivo as a model for studying permeability and pathogenesis in mucosa.
@en
P2093
P356
P1476
Porcine vagina ex vivo as a model for studying permeability and pathogenesis in mucosa.
@en
P2093
Catherine C Davis
Christopher A Squier
Mary J Mantz
P356
10.1002/JPS.21077
P407
P577
2008-01-01T00:00:00Z